Last reviewed · How we verify

NCT06886295

Clinical Evaluation of Intuitive, Bidirectional Strategies for the Control of Multi-articulated Prostheses for Upper Limb Amputation

Recruiting now NA Last updated 3 April 2025
What this trial tests

NA trial testing Prosthetic controller in Upper Limb Amputation in 14 participants. Currently enrolling.

Timeline
1 April 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorScuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment14
Start date1 April 2025
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna

Who can join

Adults 18 to 65, any sex, with Upper Limb Amputation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators propose to validate a non-invasive upper limb prosthesis capable of combining: 1) intuitive movement control through machine learning applied to myoelectric signals, and 2) vibrotactile sensory feedback in response to touch and object release events. The prosthesis is composed at the minimum of skin-surface electrodes for myoelectric signals, vibrotactile actuators, a multi-articulated and instrumented hand prosthesis and a centralized control system. Such system is validated for several weeks in non-supervised environments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Upper Limb Amputation

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06886295.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing